June 2009, Volume 3, Issue 3, Suppl 2
Juin 2009, Volume 3, Numéro 3, Suppl 2
back to CUAJ home
|
Contents - Table des matières
Introduction
Review: Benign Prostatic Hyperplasia
Review: Burden of Prostate Cancer
Review: Prostate Pathophysiology
Review: Gleason Grading |
| |
| Contents - Table des matières |
Contents - Table des matières
back to top |
| Introduction |
Sharing the responsibility of prostate cancer risk reduction
L. Klotz, Y. Fradet, L. Goldenberg, S. Tanguay
back to top |
| Review: Benign Prostatic Hyperplasia |
Diagnosis and management of benign prostatic hyperplasia
in primary care
S. Tanguay, M. Awde, G. Brock, R. Casey, J. Kozak, J. Lee,
J.C. Nickel, F. Saad
back to top |
| Review: Burden of Prostate Cancer |
The burden of prostate cancer in Canada
Y. Fradet, L. Klotz, J. Trachtenberg, A. Zlotta
back to top |
| Review: Prostate Pathophysiology |
The role of 5-alpha reductase inhibitors in prostate pathophysiology:
Is there an additional advantage to inhibition of type 1 isoenzyme?
L. Goldenberg, A. So, N. Fleshner, R. Rendon, D. Drachenberg, M. Elhilali
back to top
|
| Review: Gleason Grading |
Gleason grading controversies: what the chemoprevention trials
have taught us
L. Klotz, D. Drachenberg, Y. Fradet, F. Saad, J. Trachtenberg, A. Zlotta
back to top
|
